Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population-based cohort study.

Wajd AlkabbaniRuth Ann MarrieShawn BugdenSilvia Alessi-SeveriniJames M BoltonPaul DaeninckChristine Leong

Published in: Addiction (Abingdon, England) (2019)

In Manitoba, Canada approximately 18% of people prescribed cannabinoid medication continue using for at least 1 year. Duration of use varies with type of cannabinoid medication, age, socio-economic status and dagnosis.

Keyphrases

healthcare
adverse drug
emergency department
electronic health record